Fidelity Investments’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Buy |
24,000
+22,844
| +1,976% | +$466K | ﹤0.01% | 2965 |
|
|
2025
Q1 | $23.1K | Buy |
1,156
+75
| +7% | +$1.5K | ﹤0.01% | 4172 |
|
|
2024
Q4 | $28.8K | Buy |
1,081
+63
| +6% | +$1.68K | ﹤0.01% | 4075 |
|
|
2024
Q3 | $29K | Sell |
1,018
-202
| -17% | -$5.76K | ﹤0.01% | 4010 |
|
|
2024
Q2 | $26.6K | Buy |
1,220
+348
| +40% | +$7.58K | ﹤0.01% | 3934 |
|
|
2024
Q1 | $19.3K | Sell |
872
-73
| -8% | -$1.62K | ﹤0.01% | 4028 |
|
|
2023
Q4 | $20.4K | Sell |
945
-65
| -6% | -$1.4K | ﹤0.01% | 3936 |
|
|
2023
Q3 | $17.1K | Buy |
1,010
+349
| +53% | +$5.9K | ﹤0.01% | 3888 |
|
|
2023
Q2 | $9.07K | Sell |
661
-52
| -7% | -$713 | ﹤0.01% | 4179 |
|
|
2023
Q1 | $16.2K | Sell |
713
-61
| -8% | -$1.39K | ﹤0.01% | 3932 |
|
|
2022
Q4 | $18.2K | Sell |
774
-7
| -0.9% | -$165 | ﹤0.01% | 3811 |
|
|
2022
Q3 | $20K | Buy |
781
+224
| +40% | +$5.74K | ﹤0.01% | 3851 |
|
|
2022
Q2 | $12K | Buy |
557
+106
| +24% | +$2.28K | ﹤0.01% | 4049 |
|
|
2022
Q1 | $20K | Buy |
+451
| New | +$20K | ﹤0.01% | 4009 |
|
|
2021
Q4 | – | Sell |
-2
| Closed | – | – | 4413 |
|
|
2021
Q3 | $0 | Sell |
2
-2
| -50% | – | ﹤0.01% | 4433 |
|
|
2021
Q2 | $0 | Sell |
4
-335,241
| -100% | – | ﹤0.01% | 4330 |
|
|
2021
Q1 | $23M | Sell |
335,245
-247,706
| -42% | -$17M | ﹤0.01% | 1745 |
|
|
2020
Q4 | $39.1M | Buy |
582,951
+167,027
| +40% | +$11.2M | ﹤0.01% | 1421 |
|
|
2020
Q3 | $21.4M | Buy |
415,924
+112,456
| +37% | +$5.79M | ﹤0.01% | 1533 |
|
|
2020
Q2 | $11.4M | Buy |
+303,468
| New | +$11.4M | ﹤0.01% | 1767 |
|